Skip to main content
Follow Gene Therapy Net on X LinkedIn - Gene Therapy Net discussion group Facebook - Gene Therapy Net
 
Gene Therapy Net Newsletter  
genetherapynetbanner468x60

News: Gene Therapy Targets Chronic Pain

Scientists at New York University have developed a gene therapy for chronic pain. The technology works by targeting the NaV1.7 sodium ion channel present on neurons, which is an important component of the pain response. The researchers encoded a version of a peptide that allows a modulatory protein, called CRMP2, to bind to NaV1.7 sodium ion channels and modulate their activity. Treating neurons so that they now express this peptide interfered with the ability of CRMP2 to affect the sodium channel, reducing the transmission of pain. As chronic pain affects a large number of patients, new treatments such as this could be set to make a real difference in many lives. 

Read more…

­

News: Discount codes cell and gene therapy conferences and meeting

Several conferences and meetings have special discount codes for members of Gene Therapy Net. Take a look at https://www.genetherapynet.com/conferences.html and login to view the discount codes which can vary from 10% up to free tickets!

Read more…

­

Conference: mRNA Cancer Vaccine Summit 2023 

This unique event will unite the leading minds from the mRNA cancer vaccine community to provide a comprehensive and detailed roadmap towards accelerated discovery, translation & clinical development of an innovative next generation cancer treatment for patients in need.


Join mRNA cancer vaccine, oncology and immuno-oncology leaders (10-12 October) and stay up to date about these innovative cancer therapies, as our world class speakers navigate through:

• Next generation techniques in personalized mRNA cancer vaccines to develop a more effective vaccine
• Optimizing the antigen selection process to ensure high clinical activity & high-quality immune responses
• Understanding the standards & regulatory requirements for mRNA cancer vaccines for rapid approvals & commercial readiness
…and much much more!

Register now…

­

Conference: 2nd Lipid Nanoparticle Development Europe Summit

With lipid nanoparticles moving beyond mRNA vaccines, biopharma are racing against the clock to exploit clinical utility to deliver more complex payloads, while optimising scalability and product quality.

Following industry progress of BioNTech entering LNP cancer vaccine trials, Moderna entering $76m collaboration with Gen Bio, and Bayer-Acuitas Therapeutics partnership using LNP for gene therapy, the field shows no signs of slowing down.

In collaboration with CPI, Pfizer, GSK, this 3-day summit will reunite 100+ senior leaders, sharing exclusive data to help you maximise this non-viral delivery system's potential. The 2nd Lipid Nanoparticle Development Europe Summit (17-19 October) is committed to equipping you with actionable takeaways across end-to-end characterisation, biodistribution, formulation and scale up to supercharge your LNP pipeline development with therapeutic promise to patients. Unite in October to get ahead of the curve and exploit LNP as the hottest delivery vehicle.

Register now…

­

Conference: Gene Editing Delivery Summit

Join Editas, Beam, Tessera, Prime, and 60+ delivery and formulation experts at the Gene Editing Delivery Summit (24-26 October) to gain practical insights for your discovery, optimization, and development of gene editing delivery systems.


This is your exclusive opportunity to leverage non-human primate data and engineering strategies from the likes of Feldan and Ascidian to widen the therapeutic window of your in vivo gene editing through targeted delivery. Evaluate different systems including LNPs, AAVs, exosomes, peptide shuttles, and PNPs with Sanofi, Vesigen, and AstraZeneca to stay ahead of the curve in the latest delivery developments. Take advantage of 3 days of end-to-end content to supercharge precise extra-hepatic in vivo gene editing to patients with previously untreatable genetic diseases.

Register now…

­

Conference: TIDES Europe Hybrid Event 

Full agenda now available to view! Save on your pass for TIDES Europe 2023, the leading event in Europe that gathers 500+ industry experts looking to accelerate therapeutics to market by expediting R&D, improving CMC efficiency, and building new partnerships. The event takes place 30 Oct - 1 Nov 2023 in Amsterdam. Access new data & case studies from world-renowned speakers and companies across the entire landscape of oligonucleotides, peptides, mRNA, drug delivery and partnering strategies -- from discovery to market, with an emphasis on the European region. Use code: GTN10 for an extra 10% off!

Register now…

­

Conference: World Orphan Drug Congress Europe

The World Orphan Drug Congress (31 October – 2 November 2023) is the largest and most established orphan drugs & rare diseases meeting of its kind worldwide. Bringing together experts from the whole value chain, where you get to meet decision makers in the areas that are most applicable for your business offering.
With 1500+ potential customers in attendance there will be opportunities to find contacts who need to find solutions to challenges around the OMP legislation review and EUHTA as well as commercial and scientific issues in evidence generation, regulation, clinical trials, market access, pricing, manufacturing, gene therapy and precision medicine. Use discount code GTN20 for 20% off tickets!

Register now…

­

Conference: 5th Gene Therapy for Neurological Disorders Summit

Despite a challenging 2022 for Gene Therapy developers targeting the CNS, the recent approvals of Skysona by bluebird bio and Upstaza by PTC Therapeutics have validated the potential that gene therapies can act as transformative medicines within the CNS community.

The 5th Gene Therapy for Neurological Disorders Summit (6-9 November) is your comprehensive 4-day event to stay ahead of cutting-edge developments, overcome delivery challenges, address translational bottlenecks, and create a bulletproof clinical development strategy, to propel the next wave of CNS gene therapies forward. This summit will unite 200+ gene therapy and neurology leaders with a program designed to cater to everyone from Discovery through to Clinical Development; this is your only opportunity for a cover-to-cover discussion full of need-to-know and practical insights.

Now that the neurological gene therapy field has been given a renewed sense of direction, this is the opportunity for the community to capitalize on the start of a new wave of innovation and optimize the potential for gene therapies targeting neurological disorders.

Register now…

­

Conference: Cell Series UK 2023 

Cell 2023 (7-9 November) will bring together over 400 visionary leading innovators from global pharmaceutical organisations, top biotech companies and internationally renowned academic institutions, in three outstanding programmes specialising in the latest techniques and technologies for cell & gene therapy development and manufacturing. Benefit from over 80 cutting-edge presentations and discussions, over 10 hours of valuable networking sessions, and an exhibition hall showcasing 35+ vendor companies.

Register now…

­

Conference: Biomarkers Europe 2023

Gain insights into Biomarker approaches & accelerate timelines in drug development for oncology and immuno-related therapies at @Oxford Global’s Biomarkers Europe 2023 conference (14-15 November). Hear from and meet with the visionary leading experts in biomarker discovery, development, and analysis and expand your knowledge and discuss future priorities in the advancement and acceleration of drug development in oncology and immuno-related therapies.

Register now…

­

Conference: Precision Oncology Europe 2023 

Advance key molecular characterizations for the emergence of more targeted and precise treatments in oncology at Oxford Global’s Precision Oncology Europe 2023 conference (14-15 November). Hear from and meet with visionary leading figures in precision oncology and expand your knowledge and discuss future priorities in how companies are innovating in precision medicine, digital pathology, and molecular testing to accelerate timelines and reduce risk in drug development. 

Register now…

­

Conference: Global Bioprocessing Summit 

The industry, professionals, and scientists are actively seeking methods to delineate more precise guidelines and anticipated requirements for enhancing biopharmaceutical processing systems. Maintaining uninterrupted production is crucial for companies, making an accelerated and optimized process from research to manufacturing increasingly vital. Uncover the latest bioprocessing trends, cutting-edge technologies, and best practices in the industry. Attend the Bioprocessing Summit (16-17 November) and discover creative solutions to improve cell line process, upstream process development, downstream process development, advanced technologies & approaches, and more. Join a world-class lineup of speakers and network with key industry innovators to take your bioprocessing skills to the next level. 

Register now…

­

Conference: 5th Annual Gene Therapy Analytical Development Summit

Behind regulatory milestones like the recent accelerated FDA approval for Duchenne Muscular Dystrophy, robust and detailed analytics are the cornerstone of gene therapy development. As regulators scrutinize products more closely, accurately characterizing gene therapy products and standing behind safety and efficacy is crucial to drug developers bringing gene therapies into and through the clinic.


In this context, the 5th Annual Gene Therapy Analytical Development is returning in 2023 (27-30 November), uniting 400+ analytical experts to explore how the latest analytical methods are being developed and applied to guarantee the quality, consistency, safety, and efficacy of gene therapy products.


Join biopharma colleagues specializing in bioassays, molecular biology, physicochemical properties, quality, process development and regulation across 4 days of niche, expert presentations, and dedicated networking opportunities. This is your must-attend meeting to collaborate ideas, success and challenges to capitalize on the technological advances in analytical development to reach the ultimate goal of bringing safer, efficacious therapies to patients more quickly and effectively.

Register now…

­

Conference: International Bioprocessing and Biologics 2023

The International Bioprocessing and Biologics Forum (28-29 November)  is a premier gathering that brings together experts, researchers, and professionals from the biopharmaceutical industry to discuss the latest advancements, trends, and challenges in bioprocessing and biologics manufacturing. This forum provides a platform for knowledge exchange, networking, and collaboration among key stakeholders involved in developing life-saving therapies, vaccines, and medical treatments.

Participants will engage in insightful discussions, share best practices, and explore innovations shaping the future of bioprocessing, from sustainable production practices to personalized medicine breakthroughs.

Register now…

­

Upcoming conferences and meetings

  • 18 - 21 September 2023 - Cell & Gene Therapy Manufacturing & Commercialization US - Boston, MA
  • 18 - 21 September 2023 - BioProcess International - ATMP - Boston, MA
  • 19 September 2023 - Cell Therapy Analytics Online Symposium 2023 - Online event
  • 19 - 21 September 2023 - 2nd Cell Therapy Analytical Development Europe - Amsterdam, The Netherlands
  • 25 - 27 September 2023 - Viral Vector Characterization & Analytical Development - Boston, MA
  • 27 - 29 September 2023 - Smart Bioprocessing & Pharma 4.0 Summit - Cell & Gene Therapies - Berlin, Germany
  • 3 – 5 October 2023 - 4th Annual Gene Therapy for Ophthalmic Disorders Summit - Boston, MA
  • 10 – 12 October 2023 - mRNA Cancer Vaccine Summit 2023 - Boston, MA
  • 12 – 13 October 2023 - Medical Affairs Summit - Boston, MA
  • 12 - 13 October 2023 - Biomarkers US 2023 - San Diego, CA
  • 17 – 19 October 2023 - 2nd Innate Killer Europe Summit - London, UK
  • 17 - 19 October 2023 - 2nd Lipid Nanoparticle Development Europe Summit - Amsterdam, The Netherlands
  • 18 – 19 October 2023 - World Drug Safety Congress Americas 2023 - Boston, MA
  • 24 – 26 October 2023 - Gene Editing Delivery Summit - Boston, MA
  • 24 – 27 October 2023 - Annual Congress of the European Society of Gene and Cell Therapy - Brussels, Belgium
  • 30 October - 1 November 2023 - TIDES Europe 2023 - Oligonucleotide and Peptide Therapeutics - Amsterdam
  • 30 October - 1 November 2023 - CRISPR-Based Therapy Analytical Development Summit - Boston, MA
  • 31 October - 2 November 2023 - 14th World Orphan Drug Congress Europe - Barcelona, Spain
  • 6 - 9 November 2023 - 5th Gene Therapy for Neurological Disorders Summit - Boston, MA
  • 7 - 8 November 2023 - Cell Series UK 2023 - London, UK
  • 14 - 15 November 2023 - Precision Oncology Europe 2023 - Berlin, Germany
  • 14 - 15 November 2023 - Biomarkers Europe 2023 - Berlin, Germany
  • 16 - 17 November 2023 - Global Bioprocessing Summit - Gene & Cell Therapies - Berlin, Germany
  • 27 - 30 November 2023 - 5th Annual Gene Therapy Analytical Development Summit 2023 - Boston, MA
  • 28 - 29 November 2023 - International Bioprocessing and Biologics Forum - Berlin, Germany
  • 28 - 30 November 2023 - Donor Selection & Cell Source Summit - Cell & Gene Therapies - San Francisco, CA
  • 28 - 30 November 2023 - Cell Therapy for Autoimmune Disease Summit - Philadelphia, PA 
  • 28 - 30 November 2023 - Advanced Purification for Complex Biologics Summit - Philadelphia, PA
  • 28 - 30 November 2023 - 4th Annual CRISPR 2.0 Congress - Boston, MA
  • 4 - 6 December 2023 - Cell Therapy Analytical Development 2023 - Boston, MA
  • 4 – 7 December 2023 - Cell & Gene Therapy Manufacturing & Commercialization Europe - Dublin, Ireland
  • 13 - 14 December 2023 - Gene Therapy Process Development Summit - Philadelphia, PA




Advertise on this site?